Privia Health Group, Inc.
NASDAQ Global SelectRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Privia Health Group, Inc. (PRVA) operates as a technology-driven national physician-enablement company in the United States, collaborating with physician practices, health plans, and health systems to optimize performance, enhance patient experiences, and drive value-based care. The company provides a comprehensive platform including Privia Cloud with electronic health records (EHR), practice management, and data analytics tools; management services organization capabilities that reduce administrative burdens; single-TIN medical groups for negotiating power and clinical integration; accountable care organization (ACO) programs that engage patients, lower utilization, and improve quality metrics; and networks for payers enabling custom contracts and population health management. It serves primary care and specialist physicians across value-based care segments, targeting medical groups, employers, payers, and patients nationwide. Founded in 2007 and headquartered in Arlington, Virginia, Privia Health supports over 1,140 employees and more than 4,500 providers in its network, focusing on both in-person and virtual care delivery. In a significant recent development, the company announced the acquisition of Evolent Health's ACO business, Evolent Care Partners, in September 2025 for $100 million in cash plus up to $13 million contingent on 2025 MSSP performance, expected to close in the fourth quarter of 2025 and expand its value-based care footprint to approximately 1.5 million attributed lives while contributing positively to adjusted EBITDA in 2026. This strategic move enhances synergies with Privia's technology platform and supports geographic expansion into new markets. Additionally, Privia reported strong 2024 financial results with $1.736 billion in revenue and raised 2025 guidance, underscoring its growth in the healthcare services industry.
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position?
Cross Keys Capital Advises Neurology Group of Bergen County in Its Partnership with Privia Health
TBRG vs. PRVA: Which Stock Is the Better Value Option?
Privia Health Enters New Jersey
TBRG or PRVA: Which Is the Better Value Stock Right Now?
Privia Health Group Q1 Earnings Call Highlights
Privia Health Group, Inc. (PRVA) Q1 2026 Earnings Call Transcript
Privia Health (PRVA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Privia Health (PRVA) Misses Q1 Earnings Estimates
Privia Health Reports First Quarter 2026 Financial Results
Privia Health to Report First Quarter 2026 Results on Thursday, May 7
JPMorgan Chase & Co. Acquires 30,845 Shares of Privia Health Group, Inc. $PRVA
Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence
Privia Health Group CFO Sells $283,000 Worth of Shares to Cover Taxes
Wall Street Analysts See a 43.44% Upside in Privia Health (PRVA): Can the Stock Really Move This High?
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration
Wall Street Analysts Think Privia Health (PRVA) Could Surge 25.45%: Read This Before Placing a Bet
Privia Health Group, Inc. (PRVA) Q4 2025 Earnings Call Transcript
Privia Health (PRVA) Reports Q4 Earnings: What Key Metrics Have to Say